UNSPSC 51183802: Miglitol

This classification denotes a glucosidase inhibitor with the molecular formula C8H17NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 0V5436JAQW, chemically known as 3,4,5-piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2r-(2alpha,3beta,4alpha,5beta))- but more generally known as miglitol, which bears US NIH Compound Identifier 51577. European Medicines Agency schedules Miglitol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08958MIG.

UNSPSC 51183802 Miglitol, a Commodity code, encompasses generic pharmaceutical products for distribution through state and local government healthcare facilities. Recent solicitations under this code show state and local procurement offices buying generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing mechanisms, with vendors supplying through authorized pharmaceutical wholesalers and required compliance with FDA manufacturing standards, Drug Supply Chain Security Act certification, and cGMP protocols. The issuing bodies are primarily state agencies and regional cooperative purchasing alliances; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant buyer consolidating demand across multiple participating state and local government facilities.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, is the most recent representative opportunity under this code. The solicitation establishes multiple contracts with wholesaler relationships through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., and evaluates vendors primarily on price competitiveness (75 percent weight), with secondary criteria including fixed pricing structure (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and willingness to accept a 3 percent administrative fee (5 percent). Vendors must maintain contractual relationships with at least two of three authorized wholesalers and demonstrate pricing flexibility through multiple formats (flat price, net price, or WAC-minus structures). The contract term runs two years for new responders with optional extensions, with awards effective July 1, 2026. No specific set-aside designations or budget range is disclosed in available materials.